| Patent | Date |
|---|
Displacement device, testing device and method for leakage testing of a connection of a tip cap with a syringe
Grant 11,389,599 - Vogt , et al. July 19, 2 | 2022-07-19 |
Inspection Device
App 20220221410 - WERK; Tobias ; et al. | 2022-07-14 |
Device and method for leakage testing of a connection between a rubber stopper and a corresponding drug container
Grant 11,346,742 - Vogt , et al. May 31, 2 | 2022-05-31 |
Testing Device and Method for Testing Moving Force of a Plunger of a Syringe
App 20220134010 - Vogt; Martin ; et al. | 2022-05-05 |
In Vitro Assays as Indicator of Local Tolerance
App 20220137028 - Bruegger; Peter ; et al. | 2022-05-05 |
Vibrating inspection device for detection of particles in a liquid
Grant 11,313,808 - Werk , et al. April 26, 2 | 2022-04-26 |
Displacement Device, Testing Device and Method for Leakage Testing of a Connection of a Tip Cap with a Syringe
App 20220040416 - Vogt; Martin ; et al. | 2022-02-10 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container
App 20220042873 - Vogt; Martin ; et al. | 2022-02-10 |
Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container
App 20210389206 - Vogt; Martin ; et al. | 2021-12-16 |
Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
App 20210353753 - Adler; Michael ; et al. | 2021-11-18 |
Microdosing
App 20210346598 - ADLER; Michael ; et al. | 2021-11-11 |
Preparing a double chamber container
Grant 11,072,446 - Werk , et al. July 27, 2 | 2021-07-27 |
Compositions, Methods, And Kits For Detection Of Lipolytic Activity
App 20210096130 - MAHLER; Hanns-Christian ; et al. | 2021-04-01 |
Highly Concentrated Pharmaceutical Formulations
App 20210054092 - Adler; Michael ; et al. | 2021-02-25 |
Dosing a fluid at a volume of less than one milliliter
Grant 10,928,236 - Adler , et al. February 23, 2 | 2021-02-23 |
Device and method for container closure integrity testing
Grant 10,895,514 - Mathaes , et al. January 19, 2 | 2021-01-19 |
Closing A Chamber Of A Container For A Pharmaceutical Product
App 20200385152 - WERK; Tobias ; et al. | 2020-12-10 |
Device and method for improved closure integrity testing
Grant 10,801,913 - Mathaes , et al. October 13, 2 | 2020-10-13 |
Closing a chamber of a container for a pharmaceutical product
Grant 10,773,838 - Werk , et al. Sept | 2020-09-15 |
Device and Method for Improved Closure Integrity Testing
App 20200276394 - Mathaes; Roman ; et al. | 2020-09-03 |
Device and Method for Improved Container Closure Integrity Testing
App 20200271541 - Mathaes; Roman ; et al. | 2020-08-27 |
Highly concentrated pharmaceutical formulations
Grant 10,752,696 - Adler , et al. A | 2020-08-25 |
Vitro method and apparatus for analysing the behaviour of substances in simulated physiological environment
Grant 10,746,644 - Mahler , et al. A | 2020-08-18 |
Method for providing in a primary packaging container a dried solid product containing an active pharmaceutical ingredient
Grant 10,696,431 - Lumkemann , et al. June 30, 2 | 2020-06-30 |
Inspection Device
App 20200182836 - WERK; Tobias ; et al. | 2020-06-11 |
Vitro Method and Apparatus for Analysing the Behaviour of Substances in Simulated Physiological Environment
App 20200025664 - Mahler; Hanns-Christian ; et al. | 2020-01-23 |
Highly Concentrated Pharmaceutical Formulations
App 20190367629 - Adler; Michael ; et al. | 2019-12-05 |
In vitro method and apparatus for analysing the behaviour of substances in simulated physiological environment
Grant 10,458,891 - Mahler , et al. Oc | 2019-10-29 |
Highly concentrated pharmaceutical formulations
Grant 10,377,831 - Adler , et al. A | 2019-08-13 |
Highly concentrated pharmaceutical formulations
Grant 10,280,227 - Adler , et al. | 2019-05-07 |
Method for determining whether reconstitution of a solution in a container is completed
Grant 10,209,211 - Werk , et al. Feb | 2019-02-19 |
Multi Chamber Syringe Unit And Method Of Preparing A Multi Chamber Syringe
App 20180256818 - LUMKEMANN; Jorg ; et al. | 2018-09-13 |
Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
App 20180228895 - Adler; Michael ; et al. | 2018-08-16 |
Subcutaneous anti-HER2 antibody formulations and uses thereof
Grant 9,968,676 - Adler , et al. May 15, 2 | 2018-05-15 |
Stable, Benzyl Alcohol-free Aqueous Solution Formulations Containing Alpha-type Interferon
App 20170360891 - Grauschopf; Ulla ; et al. | 2017-12-21 |
Method For Providing In A Primary Packaging Container A Dried Solid Product Containing An Active Pharmaceutical Ingredient
App 20170341784 - Lumkemann; Jorg ; et al. | 2017-11-30 |
Preparing A Double Chamber Container
App 20170267383 - WERK; Tobias ; et al. | 2017-09-21 |
In Vitro Method And Apparatus For Analysing The Behaviour Of Substances In Simulated Physiological Environment
App 20170268976 - MAHLER; Hanns-Christian ; et al. | 2017-09-21 |
Closing A Chamber Of A Container For A Pharmaceutical Product
App 20170259948 - WERK; Tobias ; et al. | 2017-09-14 |
Dosing A Fluid At A Volume Of Less Than One Milliliter
App 20170211959 - ADLER; Michael ; et al. | 2017-07-27 |
Method for Determining Whether Reconstitution of a Solution in a Container is Completed
App 20170212068 - Werk; Tobias ; et al. | 2017-07-27 |
Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
App 20160166689 - Adler; Michael ; et al. | 2016-06-16 |
Subcutaneous anti-HER2 antibody formulations and uses thereof
Grant 9,345,661 - Adler , et al. May 24, 2 | 2016-05-24 |
Highly Concentrated Pharmaceutical Formulations
App 20160137742 - Adler; Michael ; et al. | 2016-05-19 |
Antibody Formulation
App 20150353640 - ADLER; MICHAEL ; et al. | 2015-12-10 |
Highly Concentrated Pharmaceutical Formulations
App 20150086537 - Adler; Michael ; et al. | 2015-03-26 |
Abeta Antibody Formulation
App 20150030589 - Goldbach; Pierre ; et al. | 2015-01-29 |
Method And Formulation For Reducing Aggregation Of A Macromolecule Under Physiological Conditions
App 20140308270 - Lobo; Brian ; et al. | 2014-10-16 |
Pharmaceutical Formulation Comprising An Antibody Against P-selectin And A Sugar Selected From Sucrose And Trehalose
App 20140093512 - Grauschopf; Ulla ; et al. | 2014-04-03 |
Anti-P-Selectin Antibody Formulation
App 20130251725 - Grauschopf; Ulla ; et al. | 2013-09-26 |
Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
App 20130216532 - Adler; Michael ; et al. | 2013-08-22 |
Formulation Comprising An Antibody Against P-selectin
App 20130209478 - Grauschopf; Ulla ; et al. | 2013-08-15 |
Formulation Comprising An Antibody Against P-selectin
App 20120321638 - Grauschopf; Ulla ; et al. | 2012-12-20 |
Pharmaceutical Formulation For Proteins
App 20120294866 - Mahler; Hanns-Christian ; et al. | 2012-11-22 |
Highly Concentrated, Liquid Formulations Of Anti-egfr Antibodies
App 20120076784 - Matheus; Susanne ; et al. | 2012-03-29 |
Method For Avoiding Glass Fogging
App 20120018338 - Bauer Dauphin; Isabelle ; et al. | 2012-01-26 |
Method And Formulation For Reducing Aggregation Of A Macromolecule Under Physiological Conditions
App 20110300135 - Lobo; Brian ; et al. | 2011-12-08 |
Method For Obtaining An Excipient-free Antibody Solution
App 20110236391 - Mahler; Hanns-Christian ; et al. | 2011-09-29 |
Pharmaceutical Preparation Comprising An Antibody Against The Egf Receptor
App 20110177068 - MUELLER; Robert ; et al. | 2011-07-21 |
Novel Antibody Formulation
App 20110158987 - Adler; Michael ; et al. | 2011-06-30 |
Pharmaceutical Compositions Of Igf/i Proteins
App 20110152188 - Mahler; Hanns-Christian ; et al. | 2011-06-23 |
Solid forms of anti-EGFR antibodies
Grant 7,960,516 - Matheus , et al. June 14, 2 | 2011-06-14 |
Highly Concentrated Pharmaceutical Formulations
App 20110076273 - Adler; Michael ; et al. | 2011-03-31 |
Beta antibody parenteral formulation
App 20110070225 - Goldbach; Pierre ; et al. | 2011-03-24 |
Subcutaneous anti-HER2 antibody formulations and uses thereof
App 20110044977 - Adler; Michael ; et al. | 2011-02-24 |
Method for stabilizing a protein
Grant 7,879,976 - Friess , et al. February 1, 2 | 2011-02-01 |
Pharmaceutical Composition
App 20100158919 - Dauphin; Isabelle Bauer ; et al. | 2010-06-24 |
Pharmaceutical formulation of an antibody against OX40L
App 20100098712 - Adler; Michael ; et al. | 2010-04-22 |
Novel Antibody Formulation
App 20100074903 - Grauschopf; Ulla ; et al. | 2010-03-25 |
Pharmaceutical formulation of an antibody against IL-1R
App 20090208509 - Mahler; Hanns-Christian ; et al. | 2009-08-20 |
Antibody Formulation
App 20090162352 - Adler; Michael ; et al. | 2009-06-25 |
Pharmaceutical formulation of an antibody against IL13Ralpha1
App 20090068196 - Goldbach; Pierre ; et al. | 2009-03-12 |
Method For Stabilizing A Protein
App 20080275220 - Friess; Wolfgang ; et al. | 2008-11-06 |
Lyophilised Preparation Comprising Antibodies Against The EFG Receptor
App 20080166346 - Mahler; Hanns-Christian ; et al. | 2008-07-10 |
Lyophilisate Comprising N-Diaminomethylene-2-Methyl-4,5-Di(Methylsulfonyl)Benzamide
App 20070299139 - Mahler; Hanns-Christian ; et al. | 2007-12-27 |
Highly concentrated, liquid formulations of anti-egfr antibodies
App 20070172475 - Matheus; Susanne ; et al. | 2007-07-26 |
Solid forms of anti-egfr antibodies
App 20070122411 - Matheus; Susanne ; et al. | 2007-05-31 |
Lyophilised preparation comprising antibodies against the efg receptor
App 20050220786 - Mahler, Hanns-Christian ; et al. | 2005-10-06 |
Pharmaceutical preparation comprising an antibody against the EGF receptor
App 20050175611 - Mahler, Hanns-Christian ; et al. | 2005-08-11 |
Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
App 20040170632 - Mahler, Hanns Christian ; et al. | 2004-09-02 |
| 